计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| A648065-5mg |
5mg |
现货 ![]() |
| |
| A648065-10mg |
10mg |
现货 ![]() |
| |
| A648065-25mg |
25mg |
现货 ![]() |
| |
| A648065-50mg |
50mg |
现货 ![]() |
| |
| A648065-100mg |
100mg |
现货 ![]() |
|
| 英文别名 | EN300-20353710 | MFCD00173870 | MS-24725 | US8501783, 1153 | EN300-1700040 | N-(1-acetyl-piperidin-4-yl)-N''-(adamantan-1-yl)urea | Apau (enzyme inhibitor) | N-(1-acetylpiperidin-4-yl)-N''-(adamant-1-yl)urea | SCHEMBL18464997 | AKOS030231617 | J3.137.087F |
|---|---|
| 规格或纯度 | ≥99% |
| 英文名称 | AR-9281 |
| 生化机理 | AR9281 (APAU) 是一种强效的选择性可溶性环氧化物水解酶(s-EH)抑制剂。AR-9281 可抑制人 sEH(HsEH)和鼠 sEH(MsEH),IC 50 值分别为 13.8 nM 和 1.7 nM。AR9281 可用于炎症、高血压和 2 型糖尿病的研究。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | 环氧化物氢化酶抑制剂 |
| 产品介绍 |
AR9281(APAU)是一种有效的,选择性可溶性环氧水解酶(S-EH)抑制剂。AR-9281 可抑制人 SEH(HsEH)和鼠 SEH(MsEH),IC50 值分别为 13.8 nM 和 1.7 nM。AR9281 可用于炎症,高血压和 2 型糖尿病的研究。
AR9281 (APAU) is a potent, selective soluble epoxide hydrolase (s-EH) inhibitor. AR-9281 can inhibits human sEH (HsEH) and murine sEH (MsEH) with IC 50 values of 13.8 nM and 1.7 nM, respectively. AR9281 can be used for the research of inflammation, hypertension and type 2 diabetes.
In Vitro AR-9281 (APAU) has inhibitory activity for human sEH (HsEH) and murine sEH (MsEH) with IC 50 values of 13.8 nM and 1.7 nM, respectively. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo AR-9281 (APAU) (oral, 150-200 mg/dL, for 6 weeks) enhances the therapeutic effects of EETs, slows progression of hyperglycemia, protects the myocyte structure, and reduces Ca 2+ dysregulation and SERCA remodeling in hyperglycemic rats. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: T2DM rat modelDosage: 150-200 mg/dL Administration: oral(drinking), for 6 weeks Result: Attenuated the progressive increase of blood glucose concentration and preserved mitochondrial structure and myofibril morphology in cardiac myocytes. Protected the intracellular Ca 2+ effector system. Had less downregulation of sarco(endo)plasmic reticulum Ca 2+ ATPase (SERCA) and lowed expression of hypertrophic markers. Form:Solid IC50& Target:IC50: 13.8 nM (HsEH),1.7 nM (MsEH) |
| 纯度 | ≥99% |
| ALogP | 2.1 |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | 1-(1-acetylpiperidin-4-yl)-3-(1-adamantyl)urea |
| INCHI | 1S/C18H29N3O2/c1-12(22)21-4-2-16(3-5-21)19-17(23)20-18-9-13-6-14(10-18)8-15(7-13)11-18/h13-16H,2-11H2,1H3,(H2,19,20,23) |
| InChi Key | HUDQLWBKJOMXSZ-UHFFFAOYSA-N |
| Smiles | CC(=O)N1CCC(CC1)NC(=O)NC23CC4CC(C2)CC(C4)C3 |
| Isomeric SMILES | CC(=O)N1CCC(CC1)NC(=O)NC23CC4CC(C2)CC(C4)C3 |
| 关联CAS | 913548-29-5 |
| PubChem CID | 12000797 |
| MeSH Entry Terms | 1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea;AR 9281;AR-9281;AR9281 |
| 分子量 | 319.44 |
| 溶解性 | DMSO : 25 mg/mL (78.26 mM; Need ultrasonic) |
|---|---|
| 分子量 | 319.400 g/mol |
| XLogP3 | 2.100 |
| 氢键供体数Hydrogen Bond Donor Count | 2 |
| 氢键受体数Hydrogen Bond Acceptor Count | 2 |
| 可旋转键计数Rotatable Bond Count | 2 |
| 精确质量Exact Mass | 319.226 Da |
| 单同位素质量Monoisotopic Mass | 319.226 Da |
| 拓扑极表面积Topological Polar Surface Area | 61.400 Ų |
| 重原子数Heavy Atom Count | 23 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 455.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
¥1,399.90